mRNA Vaccines

Displaying 1 - 3 of 3CSV
Wang, Q., Mellis, I. A., Guo, Y., Gherasim, C., Valdez, R., Gordon, A., Ho, D. D., & Liu, L. (2024). Robust SARS-CoV-2-neutralizing antibodies sustained through 6 months post XBB.1.5 mRNA vaccine booster. Cell Reports Medicine, 5(9), 101701. https://doi.org/10.1016/j.xcrm.2024.101701
Publication Date
Wang, Q., Guo, Y., Bowen, A., Mellis, I. A., Valdez, R., Gherasim, C., Gordon, A., Liu, L., & Ho, D. D. (2024). XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1. Cell Host & Microbe, 32(3), 315-321.e3. https://doi.org/10.1016/j.chom.2024.01.014
Publication Date
Wilks, S. H., Mühlemann, B., Shen, X., Türeli, S., LeGresley, E. B., Netzl, A., Caniza, M. A., Chacaltana-Huarcaya, J. N., Corman, V. M., Daniell, X., Datto, M. B., Dawood, F. S., Denny, T. N., Drosten, C., Fouchier, R. A. M., Garcia, P. J., Halfmann, P. J., Jassem, A., Jeworowski, L. M., … Smith, D. J. (2023). Mapping SARS-CoV-2 antigenic relationships and serological responses. Science, 382(6666). https://doi.org/10.1126/science.adj0070
Publication Date